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Abstract 
Propidium monoazide (PMA) or ethidium bromide monoazide (EMA) treatment has 
been used before nucleic acid detection methods, such as PCR, to distinguish between 
live and dead cells using membrane integrity as viability criterion. The performance of 
these DNA intercalating dyes was compared in many studies utilizing different 
microorganisms. These studies demonstrated that EMA and PMA differ in their abilities 
to identify non-viable cells from mixed cell populations, depending on the 
microorganism and the nature of the sample. Due to this heterogeneity, both dyes were 
used in the present study to specifically distinguish dead from live Candida albicans 
cells using viable-qPCR. The viable-qPCR was optimized and the best results were 
obtained when pre-treating the cells for 10 min in the dark with 25 PM EMA followed 
by continuous photoactivation for 15 min. The suitability of this technique to 
distinguish clotrimazole- and fluconazole-treated C. albicans cells from untreated cells 
was then assessed.  Furthermore, the antifungal properties of two commercial essential 
oils (Thymus vulgaris and Matricaria chamomilla) were evaluated. The viable-qPCR 
method was determined to be a feasible technique for assessing the viability of C. 
albicans after drug treatment and may help to provide a rapid diagnostic and 
susceptibility testing method for fungal infections, especially for patients treated with 
antifungal therapies. 
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Introduction 
Invasive fungal infections are an increasingly recognized cause of morbidity and 
mortality, especially in immunocompromised patients (Marr 2009; Miceli et al. 2011), 
in whom, infections due to Candida species are the most common (Pfaller et al. 2007; 
Sims et al. 2005). Candida species produce infections ranging from non-life-threatening 
mucocutaneous illnesses to invasive processes that may involve disseminated disease 
and sepsis. Due to the severity of such infections, a rapid and effective diagnostic test is 
necessary to allow a prompt and effective therapeutic intervention. In addition, a fast 
method to test for susceptibility is desired (Pappas et al. 2004).  
Identification of bacterial pathogens by traditional methods is still a crucial element of 
the diagnostic process. However, methods such as culturing and sub-culturing 
organisms, especially those that are fastidious, can be laborious and time-consuming, 
and may prolong a patient’s definitive diagnosis and treatment. While there has been 
improvement in traditional methods, clinical laboratories have begun to adopt nucleic 
acid-based methods to identify pathogens rapidly and reliably.   
Many efforts have been focused on the detection of Candida albicans using molecular 
techniques, such as quantitative PCR (qPCR) (Fricke et al. 2010; Khan et al. 2009; 
Maaroufi et al. 2003). However, the major disadvantage of qPCR is its inability to 
differentiate between viable and non-viable cells. This is especially important when 
attempting to diagnose and monitor disease; thus, there is an urgent need for adding 
viability information to DNA-based diagnostics in clinical microbiology. The DNA of 
dead cells is expected to remain stable over prolonged periods of time (Josephson et al. 
1993); thus, DNA techniques may include the dead population and overestimate the 
microorganisms present in a sample. To overcome this, selective nucleic acid 
intercalating dyes, including ethidium monoazide (EMA) and propidium monoazide 
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(PMA), have been successfully used in conjunction with qPCR (herein called viable-
qPCR) for a large spectrum of microorganisms: bacteria (Agustí et al. 2010; Chang et 
al. 2009; Elizaquível et al. 2012; Kralik et al. 2010; Kramer et al. 2009; Nocker and 
Camper 2006; Nocker et al. 2006; Rawsthorne et al. 2009; Takahashi et al. 2011), fungi 
(Andorrà et al. 2010; Rawsthorne and Phister 2009; Vesper et al. 2008), protozoans 
(Brescia et al. 2009; Fittipaldi et al. 2011; Thomas et al. 2012), and viruses (Fittipaldi et 
al. 2010; Parshionikar et al. 2010; Sánchez et al. 2012). 
The viable-PCR method uses membrane integrity as the criterion to differentiate 
between live and dead cells. Theoretically, selective nucleic acid intercalating dyes 
should only penetrate into membrane compromised cells or dead cells. The presence of 
an azide group is believed to permit cross-linking of the dye to the DNA after exposure 
to strong visible light. Photolysis of EMA and PMA converts the azide group into a 
highly reactive nitrene radical, which can react with any organic molecule in its 
proximity, including DNA. In this bound state, DNA cannot be amplified by PCR 
(Nocker and Camper 2009; Rudi et al. 2005). This promising analytical approach is still 
in development and needs to be investigated further (Fittipaldi et al. 2012).    
As mentioned above, different studies have shown the feasibility of viable-qPCR 
procedures; nevertheless, there are only four studies in fungi, which are not related with 
clinical applications (Andorrà et al. 2010; Rawsthorne and Phister 2009; Shi et al. 2012; 
Vesper et al. 2008).  
In this work, for the first time, a viable-qPCR method for C. albicans has been 
optimized. Additionally, the potential of this method to evaluate diagnostic and 
antifungal treatments was demonstrated for four antifungal substances (clotrimazole, 
fluconazole, and the essential oils, Thymus vulgaris and Matricaria chamomilla).  
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Methods 
Yeast strain and culture conditions 
The C. albicans ATCC 2091 strain was plated on Sabouraud glucose-agar (Oxoid, 
Basingstoke, UK) and incubated at 37°C for 48 h. C. albicans cells were harvested from 
the agar plates and suspended in 10 ml phosphate-buffered saline (PBS 1X, pH 7.4) to 
obtain a working yeast suspension. The cell density was adjusted to an OD600 of 0.8, 
corresponding to 5.0 x 106 cfu/ml.  
 
Antifungal products 
Clotrimazole (Sigma Aldrich, Madrid, Spain), fluconazole (Laboratorio STADA, 
Barcelona, Spain), and M. chamomilla and T. vulgaris essential oils (Plantis, Barcelona, 
Spain) were used as inactivating agents. The antifungal products were dissolved in 20% 
dimethyl sulfoxide (DMSO) solution (Sigma Aldrich, Madrid, Spain) to a final 
concentration of 10 mg/ml. The essential oils were diluted 10-fold in sterile distilled 
water.  
 
Heat treatment 
To obtain dead cells for optimization of the viable-qPCR procedure, 500 Pl of the 
working yeast suspension was heated at 85 ºC for 30 min using a standard laboratory 
heat block. The loss of viability of the cells was tested by plating 100 μl of cell 
suspension on Sabouraud glucose-agar plates, followed by incubation at 37 ºC for 48 h.  
 
Optimization of the viable-qPCR procedure  
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The efficiency of 50 PM EMA or PMA treatment was analyzed to choice the working 
intercalating dye. Once the intercalating dye was chosen, different parameters, such as 
dye concentration, photoactivation conditions, incubation time, and incubation 
temperature were evaluated to optimize the viable-qPCR method and to maximize the 
difference in crossing point (Cp) values between live and dead C. albicans cells.  
EMA and PMA (Biotium, Hayward, CA, USA) were resuspended in PCR grade water 
(VWR International Eurolab, Barcelona, Spain) to obtain stock dye solutions of 2.97 
mM and 2 mM, respectively. These stock solutions were aliquoted into dark tubes and 
stored at -20 ºC until needed.   
The EMA and PMA treatments were adapted from a basic procedure previously 
developed by Nocker and Camper (2006). Briefly, stock solutions of EMA and PMA 
were added to sample tubes containing 500 Pl viable or heat-killed cells to reach a final 
dye concentration of 50 PM for PMA and 25, 50, or 100 PM for EMA. Samples were 
incubated in the dark for 10 min to allow dye penetration into cells with damaged 
membranes. Photo-induced crosslinking of PMA or EMA was achieved by exposing the 
samples to light for 15 min using a photoactivation system (PhAST Blue, GenIUL, 
Barcelona, Spain) (Agusti et al. 2010; Elizaquível et al. 2012; Fittipaldi et al. 2010; 
Fittipaldi et al. 2011; Miotto et al. 2012; Sánchez et al. 2012). The samples were 
subsequently centrifuged at 14,100 x g for 5 min, and the cell pellets were resuspended 
in 200 Pl of PBS. In addition, 500 Pl of control samples, viable and heat-killed cells 
untreated with PMA or EMA, were concentrated by centrifugation and resuspended in 
200 Pl of PBS. 
To choice the best dye concentration, EMA treatments using different concentrations 
(25, 50 and 100 PM) were performed. 
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The experiments to optimize the photoactivation step were conducted with an EMA 
concentration of 25 PM and an incubation time of 10 min. The samples were exposed to 
different photoactivation treatments: (Treatment 1) photoactivation for 30 min with 
three on-off intervals of 10 min; (Treatment 2) double photoactivation treatment for 10 
min; or (Treatment 3) continuous photoactivation for 15 min. After photoactivation, the 
samples were centrifuged at 14,100 x g for 5 min, and the cell pellets were resuspended 
in 200 Pl of PBS. 
Different dye incubation conditions were evaluated with EMA at a final concentration 
of 25 PM for 500 Pl of viable or heat-killed cell suspensions. Then, the samples were 
incubated at different times (10, 30, or 60 min) and at two different temperatures (4 ºC 
or 22 ºC) in the dark, and were subsequently exposed to light for 15 min. The samples 
were centrifuged at 14,100 x g for 5 min, and the cell pellets were resuspended in 200 Pl 
of PBS. 
 
DNA purification 
Genomic DNA was extracted using the E.Z.N.A. Tissue DNA kit (Omega Bio-Tek, 
Doraville, USA) according to the manufacturer’s instructions. Before DNA isolation, 
the samples were exposed to a thermal shock (15 min at 99 ºC and 15 min at 0 ºC, two 
times) to improve cell lysis.  
 
Quantitative PCR protocol  
For C. albicans quantification, a qPCR procedure previously described by Maaroufi et 
al. (2003) was adapted. Sample analysis was performed on a LightCycler-1.5 PCR 
system (Roche Molecular Diagnostics, Manheim, Germany). The reaction mixture 
contained 10 μl of Fast Start Taqman Probe Master (Roche Molecular Diagnostic, 
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Mannheim, Germany), 9 μl of DNA sample, 0.2 μM of the universal fungal 
amplification primers ITS86 (5′- GTGAATCATCGAATCTTTGAAC-3’) and ITS4 (5’-
TCCTCCGCTTATTGATATGC- 3′) (Turenne et al. 1999), and 0.2 μM of the C. 
albicans specific probe CA-FAM (5′-FAM-ATTGCTTGCGGCGGTAACGTCC-
TAMRA-3′) (Shin et al. 1999). The qPCR conditions were optimized (data not shown) 
and were as follows: 10 min at 95 °C for Taq polymerase activation, and 45 cycles of 15 
s at 95 ºC, 1 min at 55 ºC, and 1 min at 72 ºC, for DNA amplification.  
 
Standard DNA curve 
A standard DNA curve was established using a 2-day C. albicans culture. DNA was 
obtained using the E.Z.N.A. Tissue DNA kit according to the manufacturer’s 
instructions. The initial amount of yeast cells was determined by culturing and by 
spectrometry measuring fluorescence at 600 nm, to be 2.0 x 106 cfu/ml. Consequently, 
serial logarithmic dilutions of the initial yeast DNA stock solution in Tris buffer (10 
mM Tris, pH 8.5) were performed. Standard DNA curve was performed by duplicate on 
a LightCycler-1.5 PCR system.  
 
Antifungal treatments 
Selection of antifungal products 
Before testing antifungal treatments by viable-qPCR, the response of C. albicans to 
different drugs (clotrimazole, fluconazole, and the essential oils, Thymus vulgaris and 
Matricaria chamomilla) was monitored by spectrometry to determine the optimal 
antifungal substances and the best cell-drug contact time. 
Briefly, in a 96-well microtiter plate, 50 Pl of the working yeast suspension were mixed 
with 100 Pl of Sabouraud glucose-broth (Oxoid, Basingstoke, UK) and 50 Pl of 
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antifungal or essential oil solution. Cell viability was continuously quantified 
spectrophotometrically at 490 nm for 24 h at 37 ºC, using a microplate reader ELISA 
(GENios-Tecan, Männedorf, Switzerland). 50 Pl of the working yeast suspension 
diluted in 150 Pl of Sabouraud glucose-broth and 200 Pl of Sabouraud glucose-broth 
were used as positive and as negative control, respectively.  
A standard curve was also constructed using serial 10-fold dilutions of the initial yeast 
suspension (OD600 of 1.6).  
 
Antifungal treatment assays 
500 Pl of C. albicans cell suspension was added to 1000 Pl of Sabouraud glucose-broth 
and 500 Pl of antifungal or essential oil solution. The cells were incubated at 37 ºC, and 
samples were taken after 16 h. Live cell number was determined using viable-qPCR and 
plate counts.  
 
Plate counts 
To determine the actual correspondence between molecular and culture counts, 0.1 ml 
of appropriate dilutions of samples from viable-PCR optimizations and antifungal 
treatment assays were spread on duplicate Sabouraud dextrose-agar plates (Oxoid, 
Basingstoke, UK) the same day that molecular analyses were carried out. Plates were 
incubated at 37 ºC for 48-72 h.  The colony number was determined using a colony 
counter (IUL, Barcelona, Spain).  
 
Statistical analysis 
Mean values and standard deviations were calculated on the basis of two independent 
experiments, each performed in duplicate. Microsoft Office Excel 2007 (Microsoft 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
11 
 
Corporation, Redmond, WA, USA) was used to determine the equations of standard 
curves, coefficients of variation, and p-values; p-values less than 0.05 (p<0.05) were 
considered statistically significant.  
 
Results 
Standard DNA curve 
Using an optimized protocol, a standard curve (y=-3.5146x + 37.665) was obtained by 
quantifying 10-fold dilutions of the DNA standard by qPCR and plotting the Cp values 
against the log10 DNA copies.  The slope value was -3.51, close to the theoretical 
optimum of -3.32 (Higuchi et al. 1993), and the correlation coefficient (R2) was 0.9999.  
Furthermore, the detection limit was calculated to be 2.0 x 101 cfu/ml. This standard 
curve was used to quantify viable cells in subsequent studies.  
 
Optimization of the viable-qPCR procedure 
Choice of the intercalating dye 
The abilities of EMA and PMA to specifically distinguish dead from viable C. albicans 
cells were compared by adding 50 PM of each dye to suspensions of live and heat-dead 
cells. As shown in Fig. 1 ((a) and (b)), similar results were obtained for viable cells 
treated with both intercalating dyes. However, with PMA treatment the number of heat-
killed cells detected was significantly higher (p<0.05) than with EMA treatment, 
showing less penetration of PMA into dead cells than with EMA (Fig. 1 (a)). Moreover, 
the greatest differences in Cp values between dye-treated and untreated dead cells (ΔCp 
dead with dye-dead without dye) and between dead and live cells treated with dye (ΔCp dead with dye-
live with dye ) were observed with EMA (Fig. 1 (b)).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
12 
 
These results indicated that EMA treatment was more effective than PMA treatment in 
discriminating dead from live C. albicans cells in the concentration evaluated (50 PM); 
therefore, EMA was chosen for subsequent experiments. 
 
Optimization of EMA concentration  
Different EMA concentrations (25, 50, and 100 PM) were evaluated to determine the 
best concentration for selective removal of genomic DNA from dead cells without the 
loss of DNA quantification from viable cell populations.  
The effect of EMA on the difference of Cp values between EMA-treated and untreated 
live cells (ΔCp live with EMA–live without EMA) was shown to increase with EMA 
concentrations of 25 and 100 PM, showing the greatest difference with an EMA 
concentration of 100 μM (Fig. 1 (d)). Therefore this concentration was more toxic to the 
live cells than treatment with EMA concentrations of 25 and 50 PM, which produced 
similar results and no significant differences in the ΔCp dead with EMA-live with EMA (Fig. 1 (c) 
and (d)).  As a result, a dye concentration of 25 PM was chosen for subsequent 
experiments. 
 
Optimization of EMA treatment 
The effects of different photoactivation treatments and different incubation conditions 
(time and temperature) were studied.  There were no significant differences on the 
EMA-DNA crosslinking (Fig. 1 (e) and (f)) between a photoactivation step with on-off 
intervals (treatment 1) and the other two treatments, a double photoactivation treatment 
(treatment 2) and a continuous photoactivation for 15 min (treatment 3).  However, 
significant differences (p<0.05) were obtained between treatment 2 and 3 on live cells 
(Fig. 1 (e) and (f)). With continuous photoactivation (treatment 3), the number of live 
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cells detected was higher than with the double photoactivation (treatment 2) (Fig. 1 (e)).  
Furthermore, when treating live cells with one (treatment 3) or two photoactivation 
treatments (treatment 2), double treatment resulted in a 2-fold increase in the ΔCp live with 
EMA–live without EMA value compared with the single continuous treatment (Fig. 1 (f)).  
These results showed the low suitability of treatment 2 compared with treatment 3.  
Moreover, in comparison to treatment 3, treatments 1 and 2 resulted in no significant 
increase in ΔCp dead with EMA–live with EMA (Fig. 1 (f)) and no significant increase in the 
cfu/ml difference between live and dead cells (Fig.1 (e)). All results indicated that the 
most suitable light treatment was treatment 3.    
A short EMA incubation of 10 min was tested along with prolonged incubations of 30 
min and 60 min to analyze the effect of EMA exposure times on the efficiency of viable 
and dead cell differentiation (Fig. 1 (g) and (h)).  For viable C. albicans cells, there were 
no statistically significant differences between the different incubation times (Fig. 1 
(g)). Conversely, significant differences were observed among the three incubation 
times in the case of dead cells (Fig. 1 (g)), with results indicating that 10 min and 60 
min were the best options. When analyzing the results through the ΔCp value (Fig. 1 
(h)), the highest values in ΔCp dead with EMA–live with EMA and in ΔCp dead with dye-dead without dye 
were obtained for 10 and 60 min of dark incubation. Moreover, similar results were 
observed in the value of ΔCp live with EMA–live without EMA for the three incubation times.  
Based on these results, and considering that 60 min is too long, an incubation time of 10 
min was selected.  
Since temperature plays a role in microbial cell membrane permeability, the effect of 
the incubation temperature in the viable-qPCR was investigated (data not shown). No 
EMA toxicity effects and no significant differences were observed between cells 
incubated with EMA at 4 and 22 ºC.  
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In summary, the optimal protocol comprised treatment with 25 PM EMA and 10 min of 
cell incubation in the dark at 22 ºC followed by continuous photoactivation for 15 min. 
These conditions were applied in the study of C. albicans cell viability after antifungal 
treatment. 
 
Antifungal susceptibility determined by viable-qPCR 
The potential use of viable-qPCR to investigate the killing of C. albicans ATCC 2091 
by antifungal substances was evaluated. The efficacy of clotrimazole, fluconazole, M. 
chamomilla, and T. vulgaris were first tested in a preliminary screening by spectrometry 
(Fig. 2).  C. albicans ATCC 2091 was shown to be highly sensitive to the action of 
clotrimazole and T. vulgaris because yeast growth was not observed when these drugs 
were used (Fig. 2). On the other hand, the C. albicans ATCC 2091 treated with 
fluconazole or M. chamomilla showed a minimum decrease in cell growth, about 0.5 
log units with respect to the Candida control (Fig. 2). Taking into account these results, 
clotrimazole, fluconazole, and T. vulgaris were used to assess C. albicans ATCC 2091 
viability by viable-qPCR after 16 h of exposure to these compounds. As shown in Fig. 3 
((a) and (b)), treatment with T. vulgaris showed a 2.5 log unit reduction in the 
population of Candida cells by viable-qPCR, indicating T. vulgaris would compromise 
the membrane integrity. Non-positive results were obtained by cell culture when heat 
and T. vulgaris treatment were used, demonstrating that both treatments completely 
killed C. albicans ATCC 2091 cells.  Similar results were observed with viable-qPCR, 
but to a lesser extent, because the amplification signals from cells treated with heat and 
T. vulgaris were not reduced completely, values were 103 and 104 cfu/ml, respectively 
(Fig. 3 (a)). When cells were treated with clotrimazole, the viability reduction 
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determined by qPCR and cell culture was 1 log unit in both cases; and no reduction was 
observed when fluconazole was used (Fig. 3 (a)).  
 
Discussion 
To our knowledge, this is the first study to demonstrate that viable-qPCR technique, 
using PMA or EMA as intercalating dye, can be used for the detection and 
quantification of live C. albicans cells.  Selective nucleic acid intercalating dyes, such 
as EMA and PMA, represent one of the most successful recent approaches to detect 
viable cells (as defined by an intact cell membrane) by PCR (Fittipaldi et al. 2012) and 
have been effectively evaluated in different microorganisms (Nocker and Camper 2006; 
Rudi et al. 2005; van Frankenhuyzen et al. 2011). As both dyes have similar structures, 
comparable results might be expected; however, some studies have showed differences 
(Andorrà et al. 2010; Cawthorn et al. 2008; Chang et al. 2010; Nam et al. 2011; Nocker 
and Camper 2009; Pan and Breidt 2007; Wagner et al. 2008). These studies showed that 
different parameters, such as the dye concentration and the microorganisms analyzed, 
play an important role in the specificity of both dyes for live and dead cells.  EMA was 
demonstrated that penetrates the membranes of live cells, and the extent of EMA entry 
into intact cells is species-dependent (Nocker and Camper 2006). Thus, multiple 
optimizations for viable-qPCR techniques have been reported focusing on EMA 
concentration, incubation time, and photoactivation time (Andorrà et al. 2010; Flekna et 
al. 2007; Minami et al. 2010; Nogva et al. 2003; Pan and Breidt 2007; Wang et al. 
2009). On the other hand, PMA has been proposed as a more appropriate alternative due 
to a comparative study showing that PMA is efficiently excluded from cells with intact 
cell membranes. Its higher selectivity is probably associated with the higher charge of 
the molecule (Nocker et al. 2006). Moreover, PMA has the advantages of a more 
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homogeneous performance and a minor cytotoxic effect with different species (Pan and 
Breidt 2007; Yañez et al. 2011). 
Taking into account these previous works, the effectiveness of PMA and EMA in 
differentiating between live and dead C. albicans cells was analyzed in the present study 
using viable-qPCR. The results showed that both dyes were suitable for the 
quantification of viable C. albicans. However, due to the fact that not significant 
differences were observed between both dyes when viable cells were treated, and since 
the ∆Cp between live and dead cells were slightly higher (12 Cp of difference) with 
EMA than with PMA (10 Cp of difference); therefore, EMA was chosen to be more 
suitable for further viable-qPCR experiments. Similar findings have been reported by 
Andorrà et al. (2010) in wine yeast. These authors showed differences between the 
mean Cp values from dead and viable cells of around 5 and 12 Cp for EMA and 6-11 
Cp for PMA, and demonstrated the suitability of both dyes in the detection of viable 
yeast in alcoholic fermentation of wine. 
In this study, viable-qPCR conditions were optimized taking into account different 
variables: EMA concentration, photoactivation treatment, and incubation conditions in 
the dark, with the aim that EMA cannot penetrate the intact cell membrane and 
suppresses the qPCR amplification signal from dead cells.  The optimal results were 
obtained when pre-treating the cells for 10 min in the dark with 25 PM EMA followed 
by continuous photoactivation for 15 min. The EMA treatment optimization results 
revealed that increasing the dye concentration, the photoactivation time, and the dye 
incubation time did not result in a higher signal reduction with heat-killed cells. In 
addition, EMA apparently cannot penetrate through the viable cell membrane; although, 
different temperatures generate changes in cell membrane fluidity and permeability 
(Van de Vossenberg et al. 1995).  Based on the results of the present study, viable-
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qPCR can be used to determine the viability of C. albicans when heat treatment is used, 
and the usefulness of this technique for yeast species was confirmed, as demonstrated 
previously for some wine yeasts (Andorrà et al. 2010) and Zygosaccharomyces bailii 
cells (Rawstorne and Phister 2009).  
Moreover, the suitability of viable-qPCR technique to determine the viability of C. 
albicans treated with antifungal therapies was assessed. Two classes of membrane-
active antifungals are commonly used in the treatment of Candida infections: the 
polyenes, which bind to ergosterol in fungal cell membranes, causing membrane 
disruption, and the azoles, such as clotrimazole and fluconazole, which inhibit synthesis 
of ergosterol, increase cellular permeability and generate changes in the membrane 
structure (Graybill 2000).  Unfortunately, the overuse of broad-spectrum antibiotics has 
resulted in the emergence of many resistant infectious pathogens, such as fluconazole-
resistant C. albicans strains (Brion et al. 2007; Gamacho-Montero et al. 2010; Martínez 
et al. 2002). Therefore, the search for a new class of therapeutic agents is critical and 
pressing (Calugi et al. 2011). Natural products, medicinal plants, and their derivatives 
have been used as new sources of alternative therapies to treat or relieve diseases 
(Gurib-Fakin 2006). T. vulgaris is an essential oil with various potent biological 
activities, including antimicrobial, antioxidant, and anti-inflammatory activities (Tsai et 
al. 2011). Numerous studies have demonstrated the irreversible effects of thymol, the 
main compound of T. vulgaris, on the cell wall, cell membrane, and cellular organelles 
(Rasooli and Owlia 2005; Tsai 2011; van Vuuren et al. 2009). 
Two drugs (clotrimazole and fluconazole) and one essential oil (T. vulgaris) were used 
to evaluate the suitability of viable-qPCR for evaluating the response of C. albicans 
ATCC 2091 to antifungal treatment. The results obtained in this study showed that the 
antifungal effect of T. vulgaris was comparable to the effect of heat inactivation; 
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whereas, there was lower impact on the cell membrane of C. albicans ATCC 2091 with 
clotrimazole and minimum impact with fluconazole. These differences obtained could 
reflect the different mechanisms of action of these compounds with respect to 
membrane damage in C. albicans. Nevertheless, even though the Cp difference 
associated with clotrimazole is not as pronounced as the Cp difference associated with 
T. vulgaris or heat inactivation, our results still demonstrate that the viable-qPCR assay 
is capable of differentiating clotrimazole-treated yeast from viable yeast. In addition, T. 
vulgaris treatment had the strongest effect on the viability of C. albicans ATCC 2091 
and this effect was similarly observed by spectrometry, viable-qPCR, and the plate 
count method.  
In conclusion, this viable-qPCR approach could be useful as an analytical tool for a 
quick diagnosis of C. albicans in clinical samples. This viable-qPCR method is an 
appropriate technique for evaluating the adequacy of pharmacotherapies in treating 
candidiasis by distinguishing between live and dead C. albicans cells. Moreover, this 
method provides a more accurate and reliable means of evaluating C. albicans 
susceptibility, to predict clinical outcome, especially in patients treated with antifungal 
therapies. 
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Figure legends 
Fig. 1 Effect of EMA or PMA pre-treatment ((a) and (b)), different EMA concentrations 
((c) and (d)), different photoactivation treatments ((e) and (f)), and different EMA 
incubation times ((g) and (h)) on cell number and Cp values obtained from live and 
heat-killed C. albicans cells. Results are presented as absolute cell numbers calculated 
from qPCR results with the help of a standard curve ((a), (c), (e) and (g)) or as the ΔCp 
differences ((b), (d), (f) and (h)). Statistically significant differences (p<0.05) are 
indicated by subscript letters. Error bars represent standard deviations obtained from 
two independent experiments, repeated in duplicate. Treatment 1, photoactivation for 30 
min with three on-off intervals of 10 min; Treatment 2, double photoactivation 
treatment for 10 min; and Treatment 3, continuous photoactivation for 15 min 
 
Fig. 2 Growth curve of C. albicans treated with clotrimazole, fluconazole, M. 
chamomilla, and T. vulgaris. Cell growth was continuously quantified 
spectrophotometrically at 490 nm for 24 h at 37 ºC. Results shown are the mean values 
from qPCR assays and are presented as log (cfu/ml) calculated from absorbance results 
with the help of a standard curve 
 
Fig. 3 Quantitation of the cell viability of C. albicans after clotrimazole, fluconazole, 
and T. vulgaris treatment by qPCR and viable-qPCR.  The standard deviations from two 
independent assays repeated in duplicate are shown by bars. Results are presented as 
cfu/ml, calculated from qPCR results with the help of a standard curve (a) or as the ΔCp 
differences (b) 
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